Royal Bank Of Canada Medicinova Inc Transaction History
Royal Bank Of Canada
- $425 Billion
- Q2 2024
A detailed history of Royal Bank Of Canada transactions in Medicinova Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 165 shares of MNOV stock, worth $334. This represents 0.0% of its overall portfolio holdings.
Number of Shares
165
Previous 380
56.58%
Holding current value
$334
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MNOV
# of Institutions
34Shares Held
4.69MCall Options Held
7.2KPut Options Held
3.8K-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$2.25 Million0.52% of portfolio
-
Black Rock Inc. New York, NY695KShares$1.41 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA623KShares$1.27 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA459KShares$931,2920.0% of portfolio
-
Citigroup Inc448KShares$909,3520.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $99.6M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...